The role of chondroprotectors in the correction of pain in patients with osteoarthritis of the joints of the hands with Heberden's nodes
- 作者: Vasilyeva L.V1, Evstratova E.F1, Suslova E.Y.1, Gostev E.V1
-
隶属关系:
- Voronezh State Medical University n.a. N.N. Burdenko
- 期: 卷 29, 编号 13 (2022)
- 页面: 87-90
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/321136
- DOI: https://doi.org/10.18565/pharmateca.2022.13.87-90
- ID: 321136
如何引用文章
详细
Background. To date, one of the main goals of drug therapy for osteoarthritis of the joints of the hands with Heberden’s nodes is to reduce pain as a result of inflammation. Alflutop is a chondroprotector based on the components of a bioactive concentrate from small marine fish, the main component of which is chondroitin sulfate. Objective. Analysis of the anti-inflammatory, analgesic effects, as well as the safety and efficacy of Alflutop in patients with osteoarthritis of the joints of the hands with Heberden’s nodes. Methods. The results of the examination and follow-up of 130 patients suffering from osteoarthritis of the joints of the hands with Heberden’s nodes are presented. Two groups were identified: group 1 (main), which consisted of 66 women aged 66.2±3.4 years, treated with alflutop 2.0 ml every other day, a course of 10 injections; group 2 (control) - 64 women aged 64.7±6.5 years who received traditional treatment with parenteral non-steroidal anti-inflammatory drugs and per os drug diacerein. Results. Assessment of laboratory and biochemical parameters studied in the groups showed a significant improvement in the main group. ESR, C-reactive protein, the number of leukocytes decreased by half already on the 20-21st day of treatment (P<0.05), and in the group 2 the decrease in these indicators was insignificant (P>0.05). Comparative analysis of the parameter «tenderness to palpation» (TTP) according to PAS showed that already on the 20-21st day of treatment with alflutop in the group 1, pain decreased to 32.9±3.1 mm and these changes were significant (P<0.001; in the control group TTP also decreased to 49.8±1.5 mm, however, pain reduction was not significant (P>0.05). The duration of morning stiffness in patients of group 1 on the 20-21st day decreased to 21.2 (19.9; 22.5) minutes (P<0.01), while in the group 2 the stiffness did not change significantly - 32.5 (31.3; 35.0) (P<0.05). All 66 (100%) patients in the group 1 completed treatment, while in the group 2 only 54 (84.4%) out of 64 patients completed the course of treatment due to adverse events. Conclusions. Safety and significant efficacy of treatment were observed in the group of patients treated with Alflutop.
全文:
![受限制的访问](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
作者简介
L. Vasilyeva
Voronezh State Medical University n.a. N.N. BurdenkoVoronezh, Russia
E. Evstratova
Voronezh State Medical University n.a. N.N. BurdenkoVoronezh, Russia
Ekaterina Suslova
Voronezh State Medical University n.a. N.N. Burdenko
Email: suslova_ekaterina2502@mail.ru
Cand. Sci. (Med.), Associate Professor, Department of Propaedeutics of Internal Diseases Voronezh, Russia
E. Gostev
Voronezh State Medical University n.a. N.N. BurdenkoVoronezh, Russia
参考
- Лила А.М., Алексеева Л.И., Таскина Е.А., Кашеварова Н.Г. Обновленные рекомендации по ведению пациентов с остеоартритом суставов кистей. Русский медицинский журнал. 2020;7:2-8.
- Самородская И.В., Степченков В.И. Сравнение подходов к терапии хондропротекторами на основании анализа клинических рекомендаций разных стран. Медицинский совет. 2020;(4):153-61. doi: 10.21518/2079-701X-2020-4-153-161.
- Lane N.E., Ivanova J., Emir B, Mobasheri A., et al. Characterization of individuals with osteoarthritis in the Unitade State and their use of prescriptions and over-the-counter suplrmentis. Maturitas. 2021;3;145:24-30. Doi: 10.1016/j. maturitas.2020.12.001.
- Алексеева Л.И., Таскина Е.А., Кашеварова Н.Г. Остеоартрит: эпидемиология, классификация, факторы риска и прогрессирования, клиника, диагностика, лечение. Современная ревматология. 2019;13(2):9-21. doi: 10.14412/1996-7012-2019-2-9-21.
- Шавловская О.А. Наумов А.В. Обновленные рекомендации Американского колледжа ревматологии по ведению пациентов с остеоартритом. 2020;4-5-6:42-52. doi: 10.21518/1561-5936-2020-4-5-6-42-52.
- Janis C. Kell New Recommendations for Hand Osteoarthritis Released. Medscape, September 07, 2018 (Electronic resource). URL: https://www.medscape.com/viewarticle/901680 (access date: 20.09.2022).
- Шарапова Е.П., Алексеева Л.И., Таскина Е.А. и др. Многоцентровое проспективное рандомизированное исследование эффективности и безопасности препарата Алфлутоп® в альтернирующем режиме по сравнению со стандартным режимом. Сообщение 2: оценка безопасности препарата при различных схемах применения. Современная ревматология. 2020;14(1):67-73. doi: 10.14412/1996-70122019-3-51-59.
- Беляева И.Б., Мазуров В.И., Трофимов Е.А. Применение биоактивного концентрата мелкой морской рыбы (препарата Алфлутоп®): 25 лет в России - исследования и практические выводы. Эффективная фармакотерапия. 2021;17(7):6-12.doi: 10.33978/2307-3586-2021-17-7-6-12
- Светлова М.С. Рентгенологическое прогрессирование остеоартрита коленных суставов на фоне длительного лечения алфлутопом (5-летнее наблюдение). Медицинский совет 2017;(1S);108-12. doi: 10.21518/2079-701X-2017-0-108-112
- Шарапова Е.П., Алексеева Л.И., Таскина Е.А. и др. Эффективность и безопасность Алфлутопа в лечении больных остеоартритом коленных суставов: многоцентровое открытое рандомизированное клиническое исследование. Фарматека. 2020;27(13):87-95. doi: 10.18565/pharmateca.2020.13.87-95
- Олюнин Ю.А. Остеоартроз суставов кистей. Дифференциальная диагностика с воспалительными заболеваниями суставов и тактика лечения. Современная ревматология. 2015;9(4):77-82. doi: 10.14412/1996-7012 2015-4-77-82
补充文件
![](/img/style/loading.gif)